This is an update on the asthma guideline from BTS/SIGN (2016).
There are lots of little changes, but probably the biggest change is that they seem to have moved away from using short-acting b2 agonists in the initial management. The first step in children is now very low-dose inhaled steroids and in adults is low-dose inhaled steroids.
Another change is that treatment should be stepped up if salbutamol is needed more than 3 times a week, rather than just 2 times a week as was previously advised.